Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Antoniou A, Pharoah P, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130
2. Berg WA, Blume JD, Cormack JB et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299(18):2151–2163
3. Bevilacqua G, Silingardi V, Marchetti P on behalf of ApreS Group, Italy (2001) Exemestane for the prevention of breast cancer in post-menopausal unaffected carriers of BRACA1/2 mutations: Aromasin Prevention Study (ApreS). Breast Cancer Res Treat 69:226. Abstract 139
4. Brandt A, Lorenzo Bermejo J, Sundquist J et al (2010) Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start? Breast Cancer Res Treat 121(1):133–141
5. Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献